RS
Therapeutic Areas
Mezzion Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Udenafil (JURVIGO®) | Improvement of exercise capacity in adolescents with Fontan physiology | Phase 3 |
| Drug | Indication | Phase |
|---|---|---|
| Udenafil (JURVIGO®) | Improvement of exercise capacity in adolescents with Fontan physiology | Phase 3 |